USFDA clears reader for Abbott FreeStyle Libre 3 system

"Our customers all over the world consistently tell us how our FreeStyle Libre technology has made an enormous, positive impact on their health and quality of life – they spend less time worrying and more time living," said Jared Watkin, senior vice president for Abbott's diabetes care business. "The FreeStyle Libre 3 reader provides more choice to people living with diabetes to have access to lifesaving technology that is smaller and easier to use and comes without the high-cost burdens of other systems."

The FreeStyle Libre 3 reader is a small handheld device that displays real-time glucose readings directly from a small sensor worn on the back of a person's upper arm, allowing them to manage their diabetes quickly and easily by viewing their glucose readings on a large, bright and easy-to-see screen.

Read also: Abbott gets USFDA clearance for FreeStyle Libre 2, FreeStyle Libre 3 sensors for integration with automated insulin delivery systems

People who use the FreeStyle Libre 3 system will still have the option to use the current FreeStyle Libre 3 smartphone apps.

The reader uses a rechargeable lithium-ion battery, which is commonly found in many other electronic devices like mobile phones. The user manual for the FreeStyle Libre 3 reader provides details on how to safely store, charge and use the device, including always using the Abbott-provided USB cable and power adapter.

Read also: USFDA approves Abbott Epic Max stented tissue valve to treat aortic regurgitation or stenosis